Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ROFLUMILAST vs ROMOSOZUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ROFLUMILAST vs ROMOSOZUMAB: Safety Overview

Metric ROFLUMILAST ROMOSOZUMAB
Total FAERS Reports 2,700 434
Deaths Reported 645 48
Death Rate 23.9% 11.1%
Hospitalizations 625 81
Average Patient Age 68.8 yrs 69.1 yrs
% Female Patients 56.3% 94.5%
FDA Approval Date Apr 17, 2023 N/A
Manufacturer Aurobindo Pharma Limited Amgen, Inc
Route ORAL SUBCUTANEOUS
Marketing Status Prescription N/A